drugset
Drugs / CoviVac
last change Feb 2024 re-read 2 minutes ago

CoviVac

Vaccine

Developed for
COVID-19
Investigated by
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products · Codagenix, Inc · Institute of Vaccines and Medical Biologicals, Vietnam · National Institute of Hygiene and Epidemiology, Vietnam · Center for Disease Control of Thai Binh Province, Vietnam · Hanoi Medical University

Trials 8 · a red edge is where a trial was stopped

today NCT05233826 · Ph 1 NCT05715918 · Ph 3 NCT05940194 · Ph 2 NCT05407142 · Ph 3 NCT05765773 · Ph 2 NCT04830800 · Ph 1 NCT04619628 · Ph 1 NCT05046548 · Ph 1/2
202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 13 trials
Phase 1 NCT05233826 Apr → Jul 2022 COVID-19 Codagenix, Inc Completed No outcome recorded
Phase 1 NCT04830800 Mar → Jun 2021 COVID-19, severe acute respiratory syndrome, viral pneumonia Institute of Vaccines and Medical Biologicals, Vietnam Completed No outcome recorded
Phase 1 NCT04619628 Dec 2020 → Jun 2021 COVID-19 Codagenix, Inc Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT05046548 Oct 2020 COVID-19 Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products Completed No outcome recorded
Phase 22 trials
Phase 2 NCT05940194 Aug → Oct 2021 COVID-19 Institute of Vaccines and Medical Biologicals, Vietnam Completed No outcome recorded
Phase 2 NCT05765773 Jul 2021 → Oct 2022 COVID-19 Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products Completed No outcome recorded
Phase 32 trials
Phase 3 NCT05715918 Apr 2022 → Dec 2023 — Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products Unknown No outcome recorded
Phase 3 NCT05407142 Jul 2021 → Jun 2023 COVID-19 Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 8 sources stand behind the page.

FieldValueCited text
Known as CoviVac “Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against...” NCT05715918 ↗
7

“Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19” NCT05046548 ↗

NCT05765773 ↗

NCT04619628 ↗

NCT05233826 ↗

NCT05940194 ↗

NCT04830800 ↗

NCT05407142 ↗
Modality Vaccine “a live attenuated vaccine to prevent COVID-19” NCT04619628 ↗
Route Intranasal “intranasal, live attenuated vaccine against SARS-CoV-2” NCT04619628 ↗